{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:18:00Z","timestamp":1783469880235,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fundo Europeu de Desenvolvimento Regional-QREN- COMPETE"},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT)","doi-asserted-by":"publisher","award":["SFRH\/BPD\/86581\/2012"],"award-info":[{"award-number":["SFRH\/BPD\/86581\/2012"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT)","doi-asserted-by":"publisher","award":["SFRH\/BPD\/86507\/2012"],"award-info":[{"award-number":["SFRH\/BPD\/86507\/2012"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centro de Quimica de Coimbra (CQC)"},{"name":"FCTUC"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.micpath.2017.02.006","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T11:31:21Z","timestamp":1486639881000},"page":"57-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Flucytosine analogues obtained through Biginelli reaction as efficient combinative antifungal agents"],"prefix":"10.1016","volume":"105","author":[{"given":"Mohmmad Younus","family":"Wani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abilio J.F.N.","family":"Sobral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2017.02.006_bib1","first-page":"14","article-title":"Emerging fungal infections in immunocompromised patients F1000","volume":"3","author":"Low","year":"2011","journal-title":"Med. Rep."},{"key":"10.1016\/j.micpath.2017.02.006_bib2","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1126\/science.aaa6097","article-title":"How to bolster the antifungal pipeline","volume":"347","author":"Denning","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.micpath.2017.02.006_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0074-7696(04)42005-1","article-title":"Multidrug resistance in yeast Candida","volume":"242","author":"Prasad","year":"2005","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.micpath.2017.02.006_bib4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S1473-3099(02)00371-7","article-title":"Antifungal drug resistance to azoles and polyenes","volume":"2","author":"Canuto","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2017.02.006_bib5","doi-asserted-by":"crossref","first-page":"e0145053","DOI":"10.1371\/journal.pone.0145053","article-title":"Synergistic interactions of eugenol-tosylate and its congeners with fluconazole against Candida albicans","volume":"22","author":"Ahmad","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2017.02.006_bib6","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1016\/j.bmc.2015.06.053","article-title":"Imidazole clubbed 1,3,4-oxadiazole derivatives as potential antifungal agents","volume":"23","author":"Wani","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.micpath.2017.02.006_bib7","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00044-016-1653-4","article-title":"Mononuclear transition metal complexes containing iodo-imidazole ring endowed with potential anti-Candida activity","volume":"25","author":"Wani","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.micpath.2017.02.006_bib8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijantimicag.2013.12.009","article-title":"Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery","volume":"43","author":"Shuyuan","year":"2014","journal-title":"Int. J. Antimicrob. Agent."},{"key":"10.1016\/j.micpath.2017.02.006_bib9","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.drudis.2014.06.009","article-title":"In pursuit of the ideal antifungal agent for Candida infections: high-throughput screening of small molecules Chaminda","volume":"19","author":"Wong","year":"2014","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.micpath.2017.02.006_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.synres.2014.07.011","article-title":"Combination screening of synthetic drugs and plant derived natural products\u2014potential and challenges for drug development","volume":"1","author":"Ulrich-Merzenich","year":"2014","journal-title":"Synergy"},{"key":"10.1016\/j.micpath.2017.02.006_bib11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nbt.1549","article-title":"Synergistic drug combinations tend to improve therapeutically relevant selectivity","volume":"27","author":"Lehar","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.micpath.2017.02.006_bib12","doi-asserted-by":"crossref","first-page":"17070","DOI":"10.1038\/srep17070","article-title":"A\u00a0combination approach to treating fungal infections","volume":"5","author":"Shrestha","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2017.02.006_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2017.02.006_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2017.02.006_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2017.02.006_bib16","first-page":"122","article-title":"The Biginelli dihydropyrimidone synthesis using polyphosphate ester as a mild and efficient cyclocondensation\/dehydration reagent","author":"Falsone","year":"2001","journal-title":"Ark. ii"},{"key":"10.1016\/j.micpath.2017.02.006_bib17","first-page":"452","article-title":"Towards new methodologies for the synthesis of biologically interesting 6-substituted pyrimidines and 4(3H)-pyrimidinones","author":"Petricci","year":"2006","journal-title":"Ark. vii"},{"key":"10.1016\/j.micpath.2017.02.006_bib18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1021\/ar000048h","article-title":"Recent advances in the Biginelli dihydropyrimidine synthesis. New tricks from an old dog","volume":"33","author":"Kappe","year":"2000","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.micpath.2017.02.006_bib19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.bmc.2013.12.010","article-title":"Synthesis and antifungal activity of substituted 2,4,6-pyrimidinetrione carbaldehyde hydrazones","volume":"22","author":"Neumann","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.micpath.2017.02.006_bib20","first-page":"109","article-title":"Biological activity of newly synthesized substituted dihydropyrimidinone and thione","volume":"4","author":"Aslam","year":"2012","journal-title":"Int. J. ChemTech Res."},{"key":"10.1016\/j.micpath.2017.02.006_bib21","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1016\/j.bmcl.2015.09.015","article-title":"Design, synthesis and biological evaluation of novel pyrazolo-pyrimidinones as DPP-IV inhibitors in diabetes","volume":"25","author":"Sagar","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.micpath.2017.02.006_bib22","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.ejmech.2008.10.002","article-title":"N1-Alkylated 3,4-dihydropyrimidine-2(1H)-ones: convenient one-pot selective synthesis and evaluation of their calcium channel blocking activity","volume":"44","author":"Singh","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.micpath.2017.02.006_bib23","series-title":"Clinical and Laboratory Standards Institute Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast, Approved Standard M27-a3","first-page":"40","author":"CLSI","year":"2008"},{"key":"10.1016\/j.micpath.2017.02.006_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/AAC.50.1.113-120.2006","article-title":"Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis","volume":"50","author":"Schwarz","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2017.02.006_bib25","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1128\/AAC.46.9.2982-2989.2002","article-title":"In\u00a0vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach","volume":"46","author":"Dorsthorst","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2017.02.006_bib26","first-page":"603","article-title":"Antifungal agents for the treatment of systemic fungal infections in children","volume":"15","author":"Allen","year":"2010","journal-title":"Paediatr. Child. Health."},{"key":"10.1016\/j.micpath.2017.02.006_bib27","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1128\/AAC.47.4.1275-1284.2003","article-title":"Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter","volume":"47","author":"No\u00ebl","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2017.02.006_bib28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1086\/514669","article-title":"Flucytosine monotherapy for cryptococcosis","volume":"27","author":"Hospenthal","year":"1998","journal-title":"Clin. Infect. Dis."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401016308257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401016308257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T11:34:41Z","timestamp":1656761681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401016308257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":28,"alternative-id":["S0882401016308257"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2017.02.006","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flucytosine analogues obtained through Biginelli reaction as efficient combinative antifungal agents","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2017.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}